Bladder Cancer LDT Receives Medicare Coverage
The Oncuria Bladder Cancer Tests, a DiaCarta validated lab developed test (LDT), received Medicare coverage effective Jan. 1, 2024.
Read More
Search Results for: bladder cancer
EarlyTect BCD a Breakthrough Device for Bladder Cancer Detection
FDA has granted Breakthrough Device Designation to EarlyTect BCD as a non-invasive, urine-based diagnostic for bladder cancer in patients with hematuria.
Read More
Genomic Urine Test Detects Bladder Cancer 12 Years Before Symptoms Appear
This genomic urine test uses next-generation DNA sequencing and machine learning to analyze urine for mutations across 60 genes linked to bladder cancer while also measuring the entire genome.
Read More
Studies on UroAmp Test for Bladder Cancer to be Presented at 2023 AUA Meeting
Convergent Genomics’ UroAmp genomic urine test for bladder cancer will be the subject of two new studies being presented at the 2023 American Urological Association Annual Meeting.
Read More
New Tech Illuminates Bladder Cancer Detection
New technology detects bladder cancer in both the clinic and operating room settings by using blue and white light, and an imaging dye.
Read More